Invention Grant
- Patent Title: GH61 polypeptide variants and polynucleotides encoding same
-
Application No.: US17714461Application Date: 2022-04-06
-
Publication No.: US11891637B2Publication Date: 2024-02-06
- Inventor: Janine Lin , Doreen Bohan , Michelle Maranta , Leslie Beresford , Michael Lamsa , Matt Sweeney , Mark David Wogulis , Elizabeth Znameroski , Frank Winther Rasmussen
- Applicant: Novozymes A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novozymes, Inc.
- Current Assignee: Novozymes, Inc.
- Current Assignee Address: US CA Davis
- Agent David A. Fazzolare
- The original application number of the division: US16269212 2019.02.06
- Main IPC: C12N9/24
- IPC: C12N9/24 ; C12P19/02 ; C12P19/14 ; C12N9/42 ; C12N9/02 ; D21C5/00 ; D21H17/00 ; C11D3/386
Abstract:
The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Public/Granted literature
- US20220307002A1 GH61 Polypeptide Variants and Polynucleotides Encoding Same Public/Granted day:2022-09-29
Information query
